Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| EXELON CORPEXC · Entity 3050 | Director · President and CEO | February 08, 2022 | February 11, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
EXELON CORP
Report date February 08, 2022 · Filed February 11, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| 2022 Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 84,243 |
Reported balance
After 2022-02-08 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-02-08 · Grant · Acquired 84,243 · Balance 84,243 F1: Restricted stock units (RSU) awarded under the Exelon Long Term Incentive Plan (LTIP). Award vests in 1/3 increments at the January or February meeting of the Exelon Compensation Committee with each RSU representing the right to receive one share of Exelon common stock upon vesting. RSUs accrue quarterly dividend equivalents in the form of additional RSUs representing common stock dividends as approved by the Board, which vest on the same schedule as the underlying RSU. |
| Earned Performance RSUSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 215,793 |
Reported balance
After 2022-02-08 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2022-02-08 · Grant · Acquired 215,793 · Balance 215,793 F4: RSUs awarded under the LTIP. Award cliff vests at the January 2023 meeting of the Exelon Compensation Committee with each RSU representing the right to receive one share of Exelon common stock upon vesting. RSUs accrue quarterly dividend equivalents in the form of additional RSUs representing common stock dividends as approved by the Board, which vest on the same schedule as the underlying RSU. In connection with Spin-Off, this award replaces the 2020 to 2022 performance share award. The Exelon Compensation Committee approved the conversion and replacement to the outstanding award target based on 2021 year-end performance, as adjusted for the Spin-Off. |
| 2021 Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 75,965 |
Reported balance
Holding disclosure · report date 2022-02-08 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 75,965 F1: Restricted stock units (RSU) awarded under the Exelon Long Term Incentive Plan (LTIP). Award vests in 1/3 increments at the January or February meeting of the Exelon Compensation Committee with each RSU representing the right to receive one share of Exelon common stock upon vesting. RSUs accrue quarterly dividend equivalents in the form of additional RSUs representing common stock dividends as approved by the Board, which vest on the same schedule as the underlying RSU. F2: In connection with the separation of Constellation Energy Corp (Constellation) from Exelon effective February 1, 2022 (the Spin-Off), the unvested balance of RSU awards outstanding immediately prior to the Spin-Off were adjusted to preserve their intrinsic value post-Spin Off. As a result, the balance of this RSU award accrued an additional 18,346 RSUs. Such adjustment is exempt from Section 16 of the Securities Exchange Act of 1934, as amended (Exchange Act) pursuant to Rule 16a-9 under the Exchange Act. The award will continue to vest on its original schedule and otherwise has substantially the same terms and conditions as the original award. |
| 2020 Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 36,190 |
Reported balance
Holding disclosure · report date 2022-02-08 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 36,190 F1: Restricted stock units (RSU) awarded under the Exelon Long Term Incentive Plan (LTIP). Award vests in 1/3 increments at the January or February meeting of the Exelon Compensation Committee with each RSU representing the right to receive one share of Exelon common stock upon vesting. RSUs accrue quarterly dividend equivalents in the form of additional RSUs representing common stock dividends as approved by the Board, which vest on the same schedule as the underlying RSU. F3: Identical adjustment as described in Note 2. As a result, the balance of this RSU award accrued an additional 8,740 RSUs. Such adjustment is exempt from Section 16 of the Securities Exchange Act of 1934, as amended (Exchange Act) pursuant to Rule 16a-9 under the Exchange Act. The award will continue to vest on its original schedule and otherwise has substantially the same terms and conditions as the original award. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units (RSU) awarded under the Exelon Long Term Incentive Plan (LTIP). Award vests in 1/3 increments at the January or February meeting of the Exelon Compensation Committee with each RSU representing the right to receive one share of Exelon common stock upon vesting. RSUs accrue quarterly dividend equivalents in the form of additional RSUs representing common stock dividends as approved by the Board, which vest on the same schedule as the underlying RSU.
F2: In connection with the separation of Constellation Energy Corp (Constellation) from Exelon effective February 1, 2022 (the Spin-Off), the unvested balance of RSU awards outstanding immediately prior to the Spin-Off were adjusted to preserve their intrinsic value post-Spin Off. As a result, the balance of this RSU award accrued an additional 18,346 RSUs. Such adjustment is exempt from Section 16 of the Securities Exchange Act of 1934, as amended (Exchange Act) pursuant to Rule 16a-9 under the Exchange Act. The award will continue to vest on its original schedule and otherwise has substantially the same terms and conditions as the original award.
F3: Identical adjustment as described in Note 2. As a result, the balance of this RSU award accrued an additional 8,740 RSUs. Such adjustment is exempt from Section 16 of the Securities Exchange Act of 1934, as amended (Exchange Act) pursuant to Rule 16a-9 under the Exchange Act. The award will continue to vest on its original schedule and otherwise has substantially the same terms and conditions as the original award.
F4: RSUs awarded under the LTIP. Award cliff vests at the January 2023 meeting of the Exelon Compensation Committee with each RSU representing the right to receive one share of Exelon common stock upon vesting. RSUs accrue quarterly dividend equivalents in the form of additional RSUs representing common stock dividends as approved by the Board, which vest on the same schedule as the underlying RSU. In connection with Spin-Off, this award replaces the 2020 to 2022 performance share award. The Exelon Compensation Committee approved the conversion and replacement to the outstanding award target based on 2021 year-end performance, as adjusted for the Spin-Off.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 08, 2022 Filed Feb 11, 2022 01:07 UTC | EXELON CORP EXC · Entity 3050 | GrantEarned Performance RSU · Derivative | 215,793 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001062993-22-003606 · form4.xml · derivative · entry 4 Crane Christopher M. · CIK 0001411453 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,793 Underlying: Common Stock · 215,793 shares Expires not disclosed F4 · price: RSUs awarded under the LTIP. Award cliff vests at the January 2023 meeting of the Exelon Compensation Committee with each RSU representing the right to receive one share of Exelon common stock upon vesting. RSUs accrue quarterly dividend equivalents in the form of additional RSUs representing common stock dividends as approved by the Board, which vest on the same schedule as the underlying RSU. In connection with Spin-Off, this award replaces the 2020 to 2022 performance share award. The Exelon Compensation Committee approved the conversion and replacement to the outstanding award target based on 2021 year-end performance, as adjusted for the Spin-Off. F4 · derivative.exercise_date: RSUs awarded under the LTIP. Award cliff vests at the January 2023 meeting of the Exelon Compensation Committee with each RSU representing the right to receive one share of Exelon common stock upon vesting. RSUs accrue quarterly dividend equivalents in the form of additional RSUs representing common stock dividends as approved by the Board, which vest on the same schedule as the underlying RSU. In connection with Spin-Off, this award replaces the 2020 to 2022 performance share award. The Exelon Compensation Committee approved the conversion and replacement to the outstanding award target based on 2021 year-end performance, as adjusted for the Spin-Off. F4 · derivative.expiration_date: RSUs awarded under the LTIP. Award cliff vests at the January 2023 meeting of the Exelon Compensation Committee with each RSU representing the right to receive one share of Exelon common stock upon vesting. RSUs accrue quarterly dividend equivalents in the form of additional RSUs representing common stock dividends as approved by the Board, which vest on the same schedule as the underlying RSU. In connection with Spin-Off, this award replaces the 2020 to 2022 performance share award. The Exelon Compensation Committee approved the conversion and replacement to the outstanding award target based on 2021 year-end performance, as adjusted for the Spin-Off. F4 · derivative.underlying_shares: RSUs awarded under the LTIP. Award cliff vests at the January 2023 meeting of the Exelon Compensation Committee with each RSU representing the right to receive one share of Exelon common stock upon vesting. RSUs accrue quarterly dividend equivalents in the form of additional RSUs representing common stock dividends as approved by the Board, which vest on the same schedule as the underlying RSU. In connection with Spin-Off, this award replaces the 2020 to 2022 performance share award. The Exelon Compensation Committee approved the conversion and replacement to the outstanding award target based on 2021 year-end performance, as adjusted for the Spin-Off. F4 · balance_after: RSUs awarded under the LTIP. Award cliff vests at the January 2023 meeting of the Exelon Compensation Committee with each RSU representing the right to receive one share of Exelon common stock upon vesting. RSUs accrue quarterly dividend equivalents in the form of additional RSUs representing common stock dividends as approved by the Board, which vest on the same schedule as the underlying RSU. In connection with Spin-Off, this award replaces the 2020 to 2022 performance share award. The Exelon Compensation Committee approved the conversion and replacement to the outstanding award target based on 2021 year-end performance, as adjusted for the Spin-Off. Read SEC document |
| February 08, 2022 Filed Feb 11, 2022 01:07 UTC | EXELON CORP EXC · Entity 3050 | Grant2022 Restricted Stock Units · Derivative | 84,243 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001062993-22-003606 · form4.xml · derivative · entry 1 Crane Christopher M. · CIK 0001411453 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,243 Underlying: Common Stock · 84,243 shares Expires not disclosed F1 · price: Restricted stock units (RSU) awarded under the Exelon Long Term Incentive Plan (LTIP). Award vests in 1/3 increments at the January or February meeting of the Exelon Compensation Committee with each RSU representing the right to receive one share of Exelon common stock upon vesting. RSUs accrue quarterly dividend equivalents in the form of additional RSUs representing common stock dividends as approved by the Board, which vest on the same schedule as the underlying RSU. F1 · derivative.exercise_date: Restricted stock units (RSU) awarded under the Exelon Long Term Incentive Plan (LTIP). Award vests in 1/3 increments at the January or February meeting of the Exelon Compensation Committee with each RSU representing the right to receive one share of Exelon common stock upon vesting. RSUs accrue quarterly dividend equivalents in the form of additional RSUs representing common stock dividends as approved by the Board, which vest on the same schedule as the underlying RSU. F1 · derivative.expiration_date: Restricted stock units (RSU) awarded under the Exelon Long Term Incentive Plan (LTIP). Award vests in 1/3 increments at the January or February meeting of the Exelon Compensation Committee with each RSU representing the right to receive one share of Exelon common stock upon vesting. RSUs accrue quarterly dividend equivalents in the form of additional RSUs representing common stock dividends as approved by the Board, which vest on the same schedule as the underlying RSU. Read SEC document |
| February 08, 2022 Filed Feb 11, 2022 01:02 UTC | EXELON CORP EXC · Entity 3050 | Exercise / conversionPerformance Shares 2019-2021 · Derivative | 109,928 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001062993-22-003592 · form4.xml · derivative · entry 7 Crane Christopher M. · CIK 0001411453 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 109,928 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Performance share award granted pursuant to the Exelon Long Term Incentive Plan for the three-year performance period referenced in Column 1 based on the Compensation Committee's determination of performance achieved for the period. Each performance share represents the right to receive one share and/or cash pursuant to the Plan's terms with respect to individual stock ownership levels. Performance share awards vest immediately upon their grant date. F2 · derivative.exercise_date: Performance share award granted pursuant to the Exelon Long Term Incentive Plan for the three-year performance period referenced in Column 1 based on the Compensation Committee's determination of performance achieved for the period. Each performance share represents the right to receive one share and/or cash pursuant to the Plan's terms with respect to individual stock ownership levels. Performance share awards vest immediately upon their grant date. F2 · derivative.expiration_date: Performance share award granted pursuant to the Exelon Long Term Incentive Plan for the three-year performance period referenced in Column 1 based on the Compensation Committee's determination of performance achieved for the period. Each performance share represents the right to receive one share and/or cash pursuant to the Plan's terms with respect to individual stock ownership levels. Performance share awards vest immediately upon their grant date. Read SEC document |
| February 08, 2022 Filed Feb 11, 2022 01:02 UTC | EXELON CORP EXC · Entity 3050 | GrantPerformance Shares 2019-2021 · Derivative | 109,928 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001062993-22-003592 · form4.xml · derivative · entry 6 Crane Christopher M. · CIK 0001411453 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,928 Underlying: Common Stock · 109,928 shares Expires not disclosed F3 · date: Performance criteria was approved by the Exelon Compensation Committee; however Mr. Crane's award amount was further subject to Exelon board approval. F2 · price: Performance share award granted pursuant to the Exelon Long Term Incentive Plan for the three-year performance period referenced in Column 1 based on the Compensation Committee's determination of performance achieved for the period. Each performance share represents the right to receive one share and/or cash pursuant to the Plan's terms with respect to individual stock ownership levels. Performance share awards vest immediately upon their grant date. F2 · derivative.exercise_date: Performance share award granted pursuant to the Exelon Long Term Incentive Plan for the three-year performance period referenced in Column 1 based on the Compensation Committee's determination of performance achieved for the period. Each performance share represents the right to receive one share and/or cash pursuant to the Plan's terms with respect to individual stock ownership levels. Performance share awards vest immediately upon their grant date. F2 · derivative.expiration_date: Performance share award granted pursuant to the Exelon Long Term Incentive Plan for the three-year performance period referenced in Column 1 based on the Compensation Committee's determination of performance achieved for the period. Each performance share represents the right to receive one share and/or cash pursuant to the Plan's terms with respect to individual stock ownership levels. Performance share awards vest immediately upon their grant date. Read SEC document |
| February 08, 2022 Filed Feb 11, 2022 01:02 UTC | EXELON CORP EXC · Entity 3050 | Disposition to issuerCommon Stock | 61,205 | $57.33 | $3,508,882.65 |
DisclosureSEC source: 0001062993-22-003592 · form4.xml · nonDerivative · entry 3 Crane Christopher M. · CIK 0001411453 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 294,252 Read SEC document |
| February 08, 2022 Filed Feb 11, 2022 01:02 UTC | EXELON CORP EXC · Entity 3050 | Tax withholdingCommon Stock | 48,723 | $57.33 | $2,793,289.59 |
DisclosureSEC source: 0001062993-22-003592 · form4.xml · nonDerivative · entry 2 Crane Christopher M. · CIK 0001411453 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 355,457 Read SEC document |
| February 08, 2022 Filed Feb 11, 2022 01:02 UTC | EXELON CORP EXC · Entity 3050 | Exercise / conversionCommon Stock | 109,928 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-22-003592 · form4.xml · nonDerivative · entry 1 Crane Christopher M. · CIK 0001411453 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 404,180 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Common shares acquired through conversion of previously granted and vested performance share award under the Exelon Long Term Incentive Plan. Read SEC document |
| January 06, 2022 Filed Jan 10, 2022 22:19 UTC | EXELON CORP EXC · Entity 3050 | Exercise / conversion2021 Restricted Stock Units · Derivative | 28,810 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001062993-22-000892 · form4.xml · derivative · entry 7 Crane Christopher M. · CIK 0001411453 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,619 Underlying: Common Stock · 28,810 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Vesting of previously granted restricted stock unit (RSU) awarded under Exelon Long Term Incentive Plan. Awards granted annually to vest in 1/3 increments at the January or February meetings of the Compensation Committee with each RSU representing the right to receive one share of Exelon common stock upon vesting. RSUs accrue quarterly dividend equivalents in the form of additional RSUs representing common stock dividends as approved by the Board, which vest on the same schedule as the underlying RSU award. F2 · derivative.exercise_date: Vesting of previously granted restricted stock unit (RSU) awarded under Exelon Long Term Incentive Plan. Awards granted annually to vest in 1/3 increments at the January or February meetings of the Compensation Committee with each RSU representing the right to receive one share of Exelon common stock upon vesting. RSUs accrue quarterly dividend equivalents in the form of additional RSUs representing common stock dividends as approved by the Board, which vest on the same schedule as the underlying RSU award. F2 · derivative.expiration_date: Vesting of previously granted restricted stock unit (RSU) awarded under Exelon Long Term Incentive Plan. Awards granted annually to vest in 1/3 increments at the January or February meetings of the Compensation Committee with each RSU representing the right to receive one share of Exelon common stock upon vesting. RSUs accrue quarterly dividend equivalents in the form of additional RSUs representing common stock dividends as approved by the Board, which vest on the same schedule as the underlying RSU award. F5 · balance_after: The RSU award accrued 2,692 additional shares during 2021 through automatic dividend reinvestment. Read SEC document |
| January 06, 2022 Filed Jan 10, 2022 22:19 UTC | EXELON CORP EXC · Entity 3050 | Exercise / conversion2020 Restricted Stock Units · Derivative | 27,450 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001062993-22-000892 · form4.xml · derivative · entry 6 Crane Christopher M. · CIK 0001411453 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,450 Underlying: Common Stock · 27,450 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Vesting of previously granted restricted stock unit (RSU) awarded under Exelon Long Term Incentive Plan. Awards granted annually to vest in 1/3 increments at the January or February meetings of the Compensation Committee with each RSU representing the right to receive one share of Exelon common stock upon vesting. RSUs accrue quarterly dividend equivalents in the form of additional RSUs representing common stock dividends as approved by the Board, which vest on the same schedule as the underlying RSU award. F2 · derivative.exercise_date: Vesting of previously granted restricted stock unit (RSU) awarded under Exelon Long Term Incentive Plan. Awards granted annually to vest in 1/3 increments at the January or February meetings of the Compensation Committee with each RSU representing the right to receive one share of Exelon common stock upon vesting. RSUs accrue quarterly dividend equivalents in the form of additional RSUs representing common stock dividends as approved by the Board, which vest on the same schedule as the underlying RSU award. F2 · derivative.expiration_date: Vesting of previously granted restricted stock unit (RSU) awarded under Exelon Long Term Incentive Plan. Awards granted annually to vest in 1/3 increments at the January or February meetings of the Compensation Committee with each RSU representing the right to receive one share of Exelon common stock upon vesting. RSUs accrue quarterly dividend equivalents in the form of additional RSUs representing common stock dividends as approved by the Board, which vest on the same schedule as the underlying RSU award. F4 · balance_after: The RSU award accrued 1,710 additional shares during 2021 through automatic dividend reinvestment. Read SEC document |
| January 06, 2022 Filed Jan 10, 2022 22:19 UTC | EXELON CORP EXC · Entity 3050 | Exercise / conversion2019 Restricted Stock Units · Derivative | 28,254 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001062993-22-000892 · form4.xml · derivative · entry 5 Crane Christopher M. · CIK 0001411453 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 28,254 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Vesting of previously granted restricted stock unit (RSU) awarded under Exelon Long Term Incentive Plan. Awards granted annually to vest in 1/3 increments at the January or February meetings of the Compensation Committee with each RSU representing the right to receive one share of Exelon common stock upon vesting. RSUs accrue quarterly dividend equivalents in the form of additional RSUs representing common stock dividends as approved by the Board, which vest on the same schedule as the underlying RSU award. F2 · derivative.exercise_date: Vesting of previously granted restricted stock unit (RSU) awarded under Exelon Long Term Incentive Plan. Awards granted annually to vest in 1/3 increments at the January or February meetings of the Compensation Committee with each RSU representing the right to receive one share of Exelon common stock upon vesting. RSUs accrue quarterly dividend equivalents in the form of additional RSUs representing common stock dividends as approved by the Board, which vest on the same schedule as the underlying RSU award. F2 · derivative.expiration_date: Vesting of previously granted restricted stock unit (RSU) awarded under Exelon Long Term Incentive Plan. Awards granted annually to vest in 1/3 increments at the January or February meetings of the Compensation Committee with each RSU representing the right to receive one share of Exelon common stock upon vesting. RSUs accrue quarterly dividend equivalents in the form of additional RSUs representing common stock dividends as approved by the Board, which vest on the same schedule as the underlying RSU award. F3 · balance_after: The RSU award accrued 880 additional shares during 2021 through automatic dividend reinvestment. Read SEC document |
| January 06, 2022 Filed Jan 10, 2022 22:19 UTC | EXELON CORP EXC · Entity 3050 | Tax withholdingCommon Stock | 34,924 | $56.73 | $1,981,238.52 |
DisclosureSEC source: 0001062993-22-000892 · form4.xml · nonDerivative · entry 2 Crane Christopher M. · CIK 0001411453 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 294,252 Read SEC document |
| January 06, 2022 Filed Jan 10, 2022 22:19 UTC | EXELON CORP EXC · Entity 3050 | Exercise / conversionCommon Stock | 84,514 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-22-000892 · form4.xml · nonDerivative · entry 1 Crane Christopher M. · CIK 0001411453 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 329,175 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Common shares acquired through conversion of previously awarded and vested restricted stock units (RSUs) under the Exelon Long Term Incentive Plan. F7 · balance_after: Balance reflects disposition of shares transferred pursuant to court-approved domestic relations order Read SEC document |
| November 19, 2021 Filed Nov 22, 2021 23:26 UTC | EXELON CORP EXC · Entity 3050 | Exercise / conversionNQ Stock Option (right to buy) 04/02/2012 · Derivative | 285,000 | Not disclosed Strike: $39.21 | Not disclosed |
DisclosureSEC source: 0001062993-21-011390 · form4.xml · derivative · entry 5 Crane Christopher M. · CIK 0001411453 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 285,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise and sale of shares were made pursuant to a Rule 10b5-1 Trading Plan entered into by Mr. Crane on November 5, 2021. F3 · price: Fully vested non-qualified stock option granted pursuant to the Exelon Long-Term Incentive Plan. Option award will expire on the 10th anniversary of the grant date referenced in column 1. F3 · derivative.exercise_date: Fully vested non-qualified stock option granted pursuant to the Exelon Long-Term Incentive Plan. Option award will expire on the 10th anniversary of the grant date referenced in column 1. F3 · derivative.expiration_date: Fully vested non-qualified stock option granted pursuant to the Exelon Long-Term Incentive Plan. Option award will expire on the 10th anniversary of the grant date referenced in column 1. Read SEC document |
| November 19, 2021 Filed Nov 22, 2021 23:26 UTC | EXELON CORP EXC · Entity 3050 | SaleCommon Stock | 285,000 | $53.49 | $15,244,650.00 |
DisclosureSEC source: 0001062993-21-011390 · form4.xml · nonDerivative · entry 2 Crane Christopher M. · CIK 0001411453 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 489,323 F1 · kind: Exercise and sale of shares were made pursuant to a Rule 10b5-1 Trading Plan entered into by Mr. Crane on November 5, 2021. F2 · price: Shares were sold in multiple lots with prices ranging from $53.22 to $53.79 inclusive. Mr Crane undertakes to provide to Exelon Corporation, any security holder of Exelon Corporation or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at at each separate price within the range provided above. Read SEC document |
| November 19, 2021 Filed Nov 22, 2021 23:26 UTC | EXELON CORP EXC · Entity 3050 | Exercise / conversionCommon Stock | 285,000 | $39.21 | $11,174,850.00 |
DisclosureSEC source: 0001062993-21-011390 · form4.xml · nonDerivative · entry 1 Crane Christopher M. · CIK 0001411453 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 774,323 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise and sale of shares were made pursuant to a Rule 10b5-1 Trading Plan entered into by Mr. Crane on November 5, 2021. F3 · price: Fully vested non-qualified stock option granted pursuant to the Exelon Long-Term Incentive Plan. Option award will expire on the 10th anniversary of the grant date referenced in column 1. Read SEC document |
| January 25, 2021 Filed Jan 26, 2021 22:29 UTC | EXELON CORP EXC · Entity 3050 | Exercise / conversionPerformance Shares 2018-2020 (stock units) · Derivative | 112,368 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001062993-21-000642 · form4.xml · derivative · entry 11 Crane Christopher M. · CIK 0001411453 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 112,368 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Performance share (stock unit) award granted pursuant to the Exelon Long Term Incentive Plan for the three-year performance period referenced in Column 1 based on the Compensation and Leadership Development Committee's determination of performance achieved for the period. Each performance share (stock unit) represents the right to receive one share or the economic equivalent value of one share of Exelon common stock. Performance share (stock units) awards vest immediately upon grant date. F3 · derivative.exercise_date: Performance share (stock unit) award granted pursuant to the Exelon Long Term Incentive Plan for the three-year performance period referenced in Column 1 based on the Compensation and Leadership Development Committee's determination of performance achieved for the period. Each performance share (stock unit) represents the right to receive one share or the economic equivalent value of one share of Exelon common stock. Performance share (stock units) awards vest immediately upon grant date. F3 · derivative.expiration_date: Performance share (stock unit) award granted pursuant to the Exelon Long Term Incentive Plan for the three-year performance period referenced in Column 1 based on the Compensation and Leadership Development Committee's determination of performance achieved for the period. Each performance share (stock unit) represents the right to receive one share or the economic equivalent value of one share of Exelon common stock. Performance share (stock units) awards vest immediately upon grant date. Read SEC document |
| January 25, 2021 Filed Jan 26, 2021 22:29 UTC | EXELON CORP EXC · Entity 3050 | GrantPerformance Shares 2018-2020 (stock units) · Derivative | 112,368 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001062993-21-000642 · form4.xml · derivative · entry 10 Crane Christopher M. · CIK 0001411453 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,368 Underlying: Common Stock · 112,368 shares Expires not disclosed F3 · price: Performance share (stock unit) award granted pursuant to the Exelon Long Term Incentive Plan for the three-year performance period referenced in Column 1 based on the Compensation and Leadership Development Committee's determination of performance achieved for the period. Each performance share (stock unit) represents the right to receive one share or the economic equivalent value of one share of Exelon common stock. Performance share (stock units) awards vest immediately upon grant date. F3 · derivative.exercise_date: Performance share (stock unit) award granted pursuant to the Exelon Long Term Incentive Plan for the three-year performance period referenced in Column 1 based on the Compensation and Leadership Development Committee's determination of performance achieved for the period. Each performance share (stock unit) represents the right to receive one share or the economic equivalent value of one share of Exelon common stock. Performance share (stock units) awards vest immediately upon grant date. F3 · derivative.expiration_date: Performance share (stock unit) award granted pursuant to the Exelon Long Term Incentive Plan for the three-year performance period referenced in Column 1 based on the Compensation and Leadership Development Committee's determination of performance achieved for the period. Each performance share (stock unit) represents the right to receive one share or the economic equivalent value of one share of Exelon common stock. Performance share (stock units) awards vest immediately upon grant date. Read SEC document |
| January 25, 2021 Filed Jan 26, 2021 22:29 UTC | EXELON CORP EXC · Entity 3050 | Grant2021 Restricted Stock Units · Derivative | 83,737 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001062993-21-000642 · form4.xml · derivative · entry 9 Crane Christopher M. · CIK 0001411453 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,737 Underlying: Common Stock · 83,737 shares Expires not disclosed F2 · price: Restricted stock unit (RSUs) award granted pursuant to the Exelon Long Term Incentive Plan. RSUs are granted annually at the Compensation and Leadership Development Committee's first meeting in January or February and vest in 1/3 increments on the dates of the Committee's January or February meetings held in the first, second, and third years after the grant date. Each RSU represents the right to receive one share of Exelon common stock. Awards accrue additional RSUs acquired through quarterly dividend reinvestment that vest on the same schedule as the underlying award. F2 · derivative.exercise_date: Restricted stock unit (RSUs) award granted pursuant to the Exelon Long Term Incentive Plan. RSUs are granted annually at the Compensation and Leadership Development Committee's first meeting in January or February and vest in 1/3 increments on the dates of the Committee's January or February meetings held in the first, second, and third years after the grant date. Each RSU represents the right to receive one share of Exelon common stock. Awards accrue additional RSUs acquired through quarterly dividend reinvestment that vest on the same schedule as the underlying award. F2 · derivative.expiration_date: Restricted stock unit (RSUs) award granted pursuant to the Exelon Long Term Incentive Plan. RSUs are granted annually at the Compensation and Leadership Development Committee's first meeting in January or February and vest in 1/3 increments on the dates of the Committee's January or February meetings held in the first, second, and third years after the grant date. Each RSU represents the right to receive one share of Exelon common stock. Awards accrue additional RSUs acquired through quarterly dividend reinvestment that vest on the same schedule as the underlying award. Read SEC document |
| January 25, 2021 Filed Jan 26, 2021 22:29 UTC | EXELON CORP EXC · Entity 3050 | Exercise / conversion2020 Restricted Stock Units · Derivative | 26,594 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001062993-21-000642 · form4.xml · derivative · entry 8 Crane Christopher M. · CIK 0001411453 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,190 Underlying: Common Stock · 26,594 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock unit (RSUs) award granted pursuant to the Exelon Long Term Incentive Plan. RSUs are granted annually at the Compensation and Leadership Development Committee's first meeting in January or February and vest in 1/3 increments on the dates of the Committee's January or February meetings held in the first, second, and third years after the grant date. Each RSU represents the right to receive one share of Exelon common stock. Awards accrue additional RSUs acquired through quarterly dividend reinvestment that vest on the same schedule as the underlying award. F2 · derivative.exercise_date: Restricted stock unit (RSUs) award granted pursuant to the Exelon Long Term Incentive Plan. RSUs are granted annually at the Compensation and Leadership Development Committee's first meeting in January or February and vest in 1/3 increments on the dates of the Committee's January or February meetings held in the first, second, and third years after the grant date. Each RSU represents the right to receive one share of Exelon common stock. Awards accrue additional RSUs acquired through quarterly dividend reinvestment that vest on the same schedule as the underlying award. F2 · derivative.expiration_date: Restricted stock unit (RSUs) award granted pursuant to the Exelon Long Term Incentive Plan. RSUs are granted annually at the Compensation and Leadership Development Committee's first meeting in January or February and vest in 1/3 increments on the dates of the Committee's January or February meetings held in the first, second, and third years after the grant date. Each RSU represents the right to receive one share of Exelon common stock. Awards accrue additional RSUs acquired through quarterly dividend reinvestment that vest on the same schedule as the underlying award. Read SEC document |
| January 25, 2021 Filed Jan 26, 2021 22:29 UTC | EXELON CORP EXC · Entity 3050 | Exercise / conversion2019 Restricted Stock Units · Derivative | 27,369 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001062993-21-000642 · form4.xml · derivative · entry 7 Crane Christopher M. · CIK 0001411453 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,374 Underlying: Common Stock · 27,369 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock unit (RSUs) award granted pursuant to the Exelon Long Term Incentive Plan. RSUs are granted annually at the Compensation and Leadership Development Committee's first meeting in January or February and vest in 1/3 increments on the dates of the Committee's January or February meetings held in the first, second, and third years after the grant date. Each RSU represents the right to receive one share of Exelon common stock. Awards accrue additional RSUs acquired through quarterly dividend reinvestment that vest on the same schedule as the underlying award. F2 · derivative.exercise_date: Restricted stock unit (RSUs) award granted pursuant to the Exelon Long Term Incentive Plan. RSUs are granted annually at the Compensation and Leadership Development Committee's first meeting in January or February and vest in 1/3 increments on the dates of the Committee's January or February meetings held in the first, second, and third years after the grant date. Each RSU represents the right to receive one share of Exelon common stock. Awards accrue additional RSUs acquired through quarterly dividend reinvestment that vest on the same schedule as the underlying award. F2 · derivative.expiration_date: Restricted stock unit (RSUs) award granted pursuant to the Exelon Long Term Incentive Plan. RSUs are granted annually at the Compensation and Leadership Development Committee's first meeting in January or February and vest in 1/3 increments on the dates of the Committee's January or February meetings held in the first, second, and third years after the grant date. Each RSU represents the right to receive one share of Exelon common stock. Awards accrue additional RSUs acquired through quarterly dividend reinvestment that vest on the same schedule as the underlying award. Read SEC document |
| January 25, 2021 Filed Jan 26, 2021 22:29 UTC | EXELON CORP EXC · Entity 3050 | Exercise / conversion2018 Restricted Stock Units · Derivative | 32,075 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001062993-21-000642 · form4.xml · derivative · entry 6 Crane Christopher M. · CIK 0001411453 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 32,075 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock unit (RSUs) award granted pursuant to the Exelon Long Term Incentive Plan. RSUs are granted annually at the Compensation and Leadership Development Committee's first meeting in January or February and vest in 1/3 increments on the dates of the Committee's January or February meetings held in the first, second, and third years after the grant date. Each RSU represents the right to receive one share of Exelon common stock. Awards accrue additional RSUs acquired through quarterly dividend reinvestment that vest on the same schedule as the underlying award. F2 · derivative.exercise_date: Restricted stock unit (RSUs) award granted pursuant to the Exelon Long Term Incentive Plan. RSUs are granted annually at the Compensation and Leadership Development Committee's first meeting in January or February and vest in 1/3 increments on the dates of the Committee's January or February meetings held in the first, second, and third years after the grant date. Each RSU represents the right to receive one share of Exelon common stock. Awards accrue additional RSUs acquired through quarterly dividend reinvestment that vest on the same schedule as the underlying award. F2 · derivative.expiration_date: Restricted stock unit (RSUs) award granted pursuant to the Exelon Long Term Incentive Plan. RSUs are granted annually at the Compensation and Leadership Development Committee's first meeting in January or February and vest in 1/3 increments on the dates of the Committee's January or February meetings held in the first, second, and third years after the grant date. Each RSU represents the right to receive one share of Exelon common stock. Awards accrue additional RSUs acquired through quarterly dividend reinvestment that vest on the same schedule as the underlying award. Read SEC document |
| January 25, 2021 Filed Jan 26, 2021 22:29 UTC | EXELON CORP EXC · Entity 3050 | Disposition to issuerCommon Stock | 62,476 | $43.35 | $2,708,334.60 |
DisclosureSEC source: 0001062993-21-000642 · form4.xml · nonDerivative · entry 3 Crane Christopher M. · CIK 0001411453 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 489,323 Read SEC document |
| January 25, 2021 Filed Jan 26, 2021 22:29 UTC | EXELON CORP EXC · Entity 3050 | Tax withholdingCommon Stock | 84,604 | $43.35 | $3,667,583.40 |
DisclosureSEC source: 0001062993-21-000642 · form4.xml · nonDerivative · entry 2 Crane Christopher M. · CIK 0001411453 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 551,799 Read SEC document |
| January 25, 2021 Filed Jan 26, 2021 22:29 UTC | EXELON CORP EXC · Entity 3050 | Exercise / conversionCommon Stock | 198,406 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-21-000642 · form4.xml · nonDerivative · entry 1 Crane Christopher M. · CIK 0001411453 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 636,403 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Common shares acquired through conversion of previously awarded and vested restricted stock units (RSUs) and performance share (stock units) under the Exelon Long Term Incentive Plan. Read SEC document |
| January 27, 2020 Filed Jan 29, 2020 17:17 UTC | EXELON CORP EXC · Entity 3050 | Exercise / conversionPerformance Shares 2017-2019 (stock units) · Derivative | 207,988 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001109357-20-000031 · edgar.xml · derivative · entry 11 Crane Christopher M. · CIK 0001411453 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 207,988 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Performance share (stock unit) award granted pursuant to the Exelon Long Term Incentive Plan for the three-year performance period referenced in Column 1 based on the Compensation and Leadership Development Committee's determination of performance achieved for the period. Each performance share (stock unit) represents the right to receive one share or the economic equivalent value of one share of Exelon common stock. Performance share (stock units) awards vest immediately upon grant date. F3 · derivative.exercise_date: Performance share (stock unit) award granted pursuant to the Exelon Long Term Incentive Plan for the three-year performance period referenced in Column 1 based on the Compensation and Leadership Development Committee's determination of performance achieved for the period. Each performance share (stock unit) represents the right to receive one share or the economic equivalent value of one share of Exelon common stock. Performance share (stock units) awards vest immediately upon grant date. F3 · derivative.expiration_date: Performance share (stock unit) award granted pursuant to the Exelon Long Term Incentive Plan for the three-year performance period referenced in Column 1 based on the Compensation and Leadership Development Committee's determination of performance achieved for the period. Each performance share (stock unit) represents the right to receive one share or the economic equivalent value of one share of Exelon common stock. Performance share (stock units) awards vest immediately upon grant date. Read SEC document |
| January 27, 2020 Filed Jan 29, 2020 17:17 UTC | EXELON CORP EXC · Entity 3050 | GrantPerformance Shares 2017-2019 (stock units) · Derivative | 207,988 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001109357-20-000031 · edgar.xml · derivative · entry 10 Crane Christopher M. · CIK 0001411453 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 207,988 Underlying: Common Stock · 207,988 shares Expires not disclosed F3 · price: Performance share (stock unit) award granted pursuant to the Exelon Long Term Incentive Plan for the three-year performance period referenced in Column 1 based on the Compensation and Leadership Development Committee's determination of performance achieved for the period. Each performance share (stock unit) represents the right to receive one share or the economic equivalent value of one share of Exelon common stock. Performance share (stock units) awards vest immediately upon grant date. F3 · derivative.exercise_date: Performance share (stock unit) award granted pursuant to the Exelon Long Term Incentive Plan for the three-year performance period referenced in Column 1 based on the Compensation and Leadership Development Committee's determination of performance achieved for the period. Each performance share (stock unit) represents the right to receive one share or the economic equivalent value of one share of Exelon common stock. Performance share (stock units) awards vest immediately upon grant date. F3 · derivative.expiration_date: Performance share (stock unit) award granted pursuant to the Exelon Long Term Incentive Plan for the three-year performance period referenced in Column 1 based on the Compensation and Leadership Development Committee's determination of performance achieved for the period. Each performance share (stock unit) represents the right to receive one share or the economic equivalent value of one share of Exelon common stock. Performance share (stock units) awards vest immediately upon grant date. Read SEC document |
| January 27, 2020 Filed Jan 29, 2020 17:17 UTC | EXELON CORP EXC · Entity 3050 | GrantRestricted Stock Units 2020 · Derivative | 76,793 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001109357-20-000031 · edgar.xml · derivative · entry 9 Crane Christopher M. · CIK 0001411453 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,793 Underlying: Common Stock · 76,793 shares Expires not disclosed F2 · price: Restricted stock unit (RSUs) award granted pursuant to the Exelon Long Term Incentive Plan. RSUs are granted annually at the Compensation and Leadership Development Committee's first meeting in January or February and vest in 1/3 increments on the dates of the Committee's January or February meetings held in the first, second, and third years after the grant date. Each RSU represents the right to receive one share of Exelon common stock. Awards accrue additional RSUs acquired through quarterly dividend reinvestment that vest on the same schedule as the underlying award. F2 · derivative.exercise_date: Restricted stock unit (RSUs) award granted pursuant to the Exelon Long Term Incentive Plan. RSUs are granted annually at the Compensation and Leadership Development Committee's first meeting in January or February and vest in 1/3 increments on the dates of the Committee's January or February meetings held in the first, second, and third years after the grant date. Each RSU represents the right to receive one share of Exelon common stock. Awards accrue additional RSUs acquired through quarterly dividend reinvestment that vest on the same schedule as the underlying award. F2 · derivative.expiration_date: Restricted stock unit (RSUs) award granted pursuant to the Exelon Long Term Incentive Plan. RSUs are granted annually at the Compensation and Leadership Development Committee's first meeting in January or February and vest in 1/3 increments on the dates of the Committee's January or February meetings held in the first, second, and third years after the grant date. Each RSU represents the right to receive one share of Exelon common stock. Awards accrue additional RSUs acquired through quarterly dividend reinvestment that vest on the same schedule as the underlying award. Read SEC document |
| January 27, 2020 Filed Jan 29, 2020 17:17 UTC | EXELON CORP EXC · Entity 3050 | Exercise / conversionRestricted Stock Units 2019 · Derivative | 26,343 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001109357-20-000031 · edgar.xml · derivative · entry 8 Crane Christopher M. · CIK 0001411453 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,691 Underlying: Common Stock · 26,343 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock unit (RSUs) award granted pursuant to the Exelon Long Term Incentive Plan. RSUs are granted annually at the Compensation and Leadership Development Committee's first meeting in January or February and vest in 1/3 increments on the dates of the Committee's January or February meetings held in the first, second, and third years after the grant date. Each RSU represents the right to receive one share of Exelon common stock. Awards accrue additional RSUs acquired through quarterly dividend reinvestment that vest on the same schedule as the underlying award. F2 · derivative.exercise_date: Restricted stock unit (RSUs) award granted pursuant to the Exelon Long Term Incentive Plan. RSUs are granted annually at the Compensation and Leadership Development Committee's first meeting in January or February and vest in 1/3 increments on the dates of the Committee's January or February meetings held in the first, second, and third years after the grant date. Each RSU represents the right to receive one share of Exelon common stock. Awards accrue additional RSUs acquired through quarterly dividend reinvestment that vest on the same schedule as the underlying award. F2 · derivative.expiration_date: Restricted stock unit (RSUs) award granted pursuant to the Exelon Long Term Incentive Plan. RSUs are granted annually at the Compensation and Leadership Development Committee's first meeting in January or February and vest in 1/3 increments on the dates of the Committee's January or February meetings held in the first, second, and third years after the grant date. Each RSU represents the right to receive one share of Exelon common stock. Awards accrue additional RSUs acquired through quarterly dividend reinvestment that vest on the same schedule as the underlying award. Read SEC document |
| January 27, 2020 Filed Jan 29, 2020 17:17 UTC | EXELON CORP EXC · Entity 3050 | Exercise / conversionRestricted Stock Units 2018 · Derivative | 30,866 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001109357-20-000031 · edgar.xml · derivative · entry 7 Crane Christopher M. · CIK 0001411453 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,873 Underlying: Common Stock · 30,866 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock unit (RSUs) award granted pursuant to the Exelon Long Term Incentive Plan. RSUs are granted annually at the Compensation and Leadership Development Committee's first meeting in January or February and vest in 1/3 increments on the dates of the Committee's January or February meetings held in the first, second, and third years after the grant date. Each RSU represents the right to receive one share of Exelon common stock. Awards accrue additional RSUs acquired through quarterly dividend reinvestment that vest on the same schedule as the underlying award. F2 · derivative.exercise_date: Restricted stock unit (RSUs) award granted pursuant to the Exelon Long Term Incentive Plan. RSUs are granted annually at the Compensation and Leadership Development Committee's first meeting in January or February and vest in 1/3 increments on the dates of the Committee's January or February meetings held in the first, second, and third years after the grant date. Each RSU represents the right to receive one share of Exelon common stock. Awards accrue additional RSUs acquired through quarterly dividend reinvestment that vest on the same schedule as the underlying award. F2 · derivative.expiration_date: Restricted stock unit (RSUs) award granted pursuant to the Exelon Long Term Incentive Plan. RSUs are granted annually at the Compensation and Leadership Development Committee's first meeting in January or February and vest in 1/3 increments on the dates of the Committee's January or February meetings held in the first, second, and third years after the grant date. Each RSU represents the right to receive one share of Exelon common stock. Awards accrue additional RSUs acquired through quarterly dividend reinvestment that vest on the same schedule as the underlying award. Read SEC document |
| January 27, 2020 Filed Jan 29, 2020 17:17 UTC | EXELON CORP EXC · Entity 3050 | Exercise / conversionRestricted Stock Units 2017 · Derivative | 34,955 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001109357-20-000031 · edgar.xml · derivative · entry 6 Crane Christopher M. · CIK 0001411453 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 34,955 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock unit (RSUs) award granted pursuant to the Exelon Long Term Incentive Plan. RSUs are granted annually at the Compensation and Leadership Development Committee's first meeting in January or February and vest in 1/3 increments on the dates of the Committee's January or February meetings held in the first, second, and third years after the grant date. Each RSU represents the right to receive one share of Exelon common stock. Awards accrue additional RSUs acquired through quarterly dividend reinvestment that vest on the same schedule as the underlying award. F2 · derivative.exercise_date: Restricted stock unit (RSUs) award granted pursuant to the Exelon Long Term Incentive Plan. RSUs are granted annually at the Compensation and Leadership Development Committee's first meeting in January or February and vest in 1/3 increments on the dates of the Committee's January or February meetings held in the first, second, and third years after the grant date. Each RSU represents the right to receive one share of Exelon common stock. Awards accrue additional RSUs acquired through quarterly dividend reinvestment that vest on the same schedule as the underlying award. F2 · derivative.expiration_date: Restricted stock unit (RSUs) award granted pursuant to the Exelon Long Term Incentive Plan. RSUs are granted annually at the Compensation and Leadership Development Committee's first meeting in January or February and vest in 1/3 increments on the dates of the Committee's January or February meetings held in the first, second, and third years after the grant date. Each RSU represents the right to receive one share of Exelon common stock. Awards accrue additional RSUs acquired through quarterly dividend reinvestment that vest on the same schedule as the underlying award. Read SEC document |
| January 27, 2020 Filed Jan 29, 2020 17:17 UTC | EXELON CORP EXC · Entity 3050 | Disposition to issuerCommon Stock | 115,324 | $47.27 | $5,451,365.48 |
DisclosureSEC source: 0001109357-20-000031 · edgar.xml · nonDerivative · entry 3 Crane Christopher M. · CIK 0001411453 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 437,997 Read SEC document |
| January 27, 2020 Filed Jan 29, 2020 17:17 UTC | EXELON CORP EXC · Entity 3050 | Tax withholdingCommon Stock | 130,471 | $47.27 | $6,167,364.17 |
DisclosureSEC source: 0001109357-20-000031 · edgar.xml · nonDerivative · entry 2 Crane Christopher M. · CIK 0001411453 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 553,321 Read SEC document |
| January 27, 2020 Filed Jan 29, 2020 17:17 UTC | EXELON CORP EXC · Entity 3050 | Exercise / conversionCommon Stock | 300,152 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001109357-20-000031 · edgar.xml · nonDerivative · entry 1 Crane Christopher M. · CIK 0001411453 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 683,792 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Common shares acquired through conversion of previously awarded and vested restricted stock units (RSUs) and performance share (stock units) under the Exelon Long Term Incentive Plan. Read SEC document |
| February 04, 2019 Filed Feb 6, 2019 22:28 UTC | EXELON CORP EXC · Entity 3050 | Exercise / conversionPerformance Shares 2016-2018 (stock units) · Derivative | 423,100 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001109357-19-000028 · edgar.xml · derivative · entry 11 Crane Christopher M. · CIK 0001411453 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 423,100 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Performance share (stock unit) award granted pursuant to the Exelon Long Term Incentive Plan for the three-year performance period of January 1, 2016 to December 31, 2018, based on the Compensation and Leadership Development Committee's determination of performance achieved for the period. Each performance share (stock unit) represents the right to receive one share or the economic equivalent value of one share of Exelon common stock. Performance share (stock units) awards vest immediately upon grant date. F3 · derivative.exercise_date: Performance share (stock unit) award granted pursuant to the Exelon Long Term Incentive Plan for the three-year performance period of January 1, 2016 to December 31, 2018, based on the Compensation and Leadership Development Committee's determination of performance achieved for the period. Each performance share (stock unit) represents the right to receive one share or the economic equivalent value of one share of Exelon common stock. Performance share (stock units) awards vest immediately upon grant date. F3 · derivative.expiration_date: Performance share (stock unit) award granted pursuant to the Exelon Long Term Incentive Plan for the three-year performance period of January 1, 2016 to December 31, 2018, based on the Compensation and Leadership Development Committee's determination of performance achieved for the period. Each performance share (stock unit) represents the right to receive one share or the economic equivalent value of one share of Exelon common stock. Performance share (stock units) awards vest immediately upon grant date. Read SEC document |
| February 04, 2019 Filed Feb 6, 2019 22:28 UTC | EXELON CORP EXC · Entity 3050 | GrantPerformance Shares 2016-2018 (stock units) · Derivative | 423,100 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001109357-19-000028 · edgar.xml · derivative · entry 10 Crane Christopher M. · CIK 0001411453 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 423,100 Underlying: Common Stock · 423,100 shares Expires not disclosed F3 · price: Performance share (stock unit) award granted pursuant to the Exelon Long Term Incentive Plan for the three-year performance period of January 1, 2016 to December 31, 2018, based on the Compensation and Leadership Development Committee's determination of performance achieved for the period. Each performance share (stock unit) represents the right to receive one share or the economic equivalent value of one share of Exelon common stock. Performance share (stock units) awards vest immediately upon grant date. F3 · derivative.exercise_date: Performance share (stock unit) award granted pursuant to the Exelon Long Term Incentive Plan for the three-year performance period of January 1, 2016 to December 31, 2018, based on the Compensation and Leadership Development Committee's determination of performance achieved for the period. Each performance share (stock unit) represents the right to receive one share or the economic equivalent value of one share of Exelon common stock. Performance share (stock units) awards vest immediately upon grant date. F3 · derivative.expiration_date: Performance share (stock unit) award granted pursuant to the Exelon Long Term Incentive Plan for the three-year performance period of January 1, 2016 to December 31, 2018, based on the Compensation and Leadership Development Committee's determination of performance achieved for the period. Each performance share (stock unit) represents the right to receive one share or the economic equivalent value of one share of Exelon common stock. Performance share (stock units) awards vest immediately upon grant date. Read SEC document |
| February 04, 2019 Filed Feb 6, 2019 22:28 UTC | EXELON CORP EXC · Entity 3050 | GrantRestricted Stock Units 2019 · Derivative | 76,680 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001109357-19-000028 · edgar.xml · derivative · entry 9 Crane Christopher M. · CIK 0001411453 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,680 Underlying: Common Stock · 76,680 shares Expires not disclosed F2 · price: Restricted stock unit (RSUs) award granted pursuant to the Exelon Long Term Incentive Plan. RSUs are granted annually at the Compensation and Leadership Development Committee's first meeting in January or February and vest in 1/3 increments on the dates of the Committee's January or February meetings held in the first, second, and third years after the grant date. Each RSU represents the right to receive one share of Exelon common stock. Awards accrue additional RSUs acquired through quarterly dividend reinvestment that vest on the same schedule as the underlying award. F2 · derivative.exercise_date: Restricted stock unit (RSUs) award granted pursuant to the Exelon Long Term Incentive Plan. RSUs are granted annually at the Compensation and Leadership Development Committee's first meeting in January or February and vest in 1/3 increments on the dates of the Committee's January or February meetings held in the first, second, and third years after the grant date. Each RSU represents the right to receive one share of Exelon common stock. Awards accrue additional RSUs acquired through quarterly dividend reinvestment that vest on the same schedule as the underlying award. F2 · derivative.expiration_date: Restricted stock unit (RSUs) award granted pursuant to the Exelon Long Term Incentive Plan. RSUs are granted annually at the Compensation and Leadership Development Committee's first meeting in January or February and vest in 1/3 increments on the dates of the Committee's January or February meetings held in the first, second, and third years after the grant date. Each RSU represents the right to receive one share of Exelon common stock. Awards accrue additional RSUs acquired through quarterly dividend reinvestment that vest on the same schedule as the underlying award. Read SEC document |
| February 04, 2019 Filed Feb 6, 2019 22:28 UTC | EXELON CORP EXC · Entity 3050 | Exercise / conversionRestricted Stock Units 2018 · Derivative | 29,949 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001109357-19-000028 · edgar.xml · derivative · entry 8 Crane Christopher M. · CIK 0001411453 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,900 Underlying: Common Stock · 29,949 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock unit (RSUs) award granted pursuant to the Exelon Long Term Incentive Plan. RSUs are granted annually at the Compensation and Leadership Development Committee's first meeting in January or February and vest in 1/3 increments on the dates of the Committee's January or February meetings held in the first, second, and third years after the grant date. Each RSU represents the right to receive one share of Exelon common stock. Awards accrue additional RSUs acquired through quarterly dividend reinvestment that vest on the same schedule as the underlying award. F2 · derivative.exercise_date: Restricted stock unit (RSUs) award granted pursuant to the Exelon Long Term Incentive Plan. RSUs are granted annually at the Compensation and Leadership Development Committee's first meeting in January or February and vest in 1/3 increments on the dates of the Committee's January or February meetings held in the first, second, and third years after the grant date. Each RSU represents the right to receive one share of Exelon common stock. Awards accrue additional RSUs acquired through quarterly dividend reinvestment that vest on the same schedule as the underlying award. F2 · derivative.expiration_date: Restricted stock unit (RSUs) award granted pursuant to the Exelon Long Term Incentive Plan. RSUs are granted annually at the Compensation and Leadership Development Committee's first meeting in January or February and vest in 1/3 increments on the dates of the Committee's January or February meetings held in the first, second, and third years after the grant date. Each RSU represents the right to receive one share of Exelon common stock. Awards accrue additional RSUs acquired through quarterly dividend reinvestment that vest on the same schedule as the underlying award. Read SEC document |
| February 04, 2019 Filed Feb 6, 2019 22:28 UTC | EXELON CORP EXC · Entity 3050 | Exercise / conversionRestricted Stock Units 2017 · Derivative | 33,909 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001109357-19-000028 · edgar.xml · derivative · entry 7 Crane Christopher M. · CIK 0001411453 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,914 Underlying: Common Stock · 33,909 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock unit (RSUs) award granted pursuant to the Exelon Long Term Incentive Plan. RSUs are granted annually at the Compensation and Leadership Development Committee's first meeting in January or February and vest in 1/3 increments on the dates of the Committee's January or February meetings held in the first, second, and third years after the grant date. Each RSU represents the right to receive one share of Exelon common stock. Awards accrue additional RSUs acquired through quarterly dividend reinvestment that vest on the same schedule as the underlying award. F2 · derivative.exercise_date: Restricted stock unit (RSUs) award granted pursuant to the Exelon Long Term Incentive Plan. RSUs are granted annually at the Compensation and Leadership Development Committee's first meeting in January or February and vest in 1/3 increments on the dates of the Committee's January or February meetings held in the first, second, and third years after the grant date. Each RSU represents the right to receive one share of Exelon common stock. Awards accrue additional RSUs acquired through quarterly dividend reinvestment that vest on the same schedule as the underlying award. F2 · derivative.expiration_date: Restricted stock unit (RSUs) award granted pursuant to the Exelon Long Term Incentive Plan. RSUs are granted annually at the Compensation and Leadership Development Committee's first meeting in January or February and vest in 1/3 increments on the dates of the Committee's January or February meetings held in the first, second, and third years after the grant date. Each RSU represents the right to receive one share of Exelon common stock. Awards accrue additional RSUs acquired through quarterly dividend reinvestment that vest on the same schedule as the underlying award. Read SEC document |
| February 04, 2019 Filed Feb 6, 2019 22:28 UTC | EXELON CORP EXC · Entity 3050 | Exercise / conversionRestricted Stock Units 2016 · Derivative | 45,382 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001109357-19-000028 · edgar.xml · derivative · entry 6 Crane Christopher M. · CIK 0001411453 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 45,382 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock unit (RSUs) award granted pursuant to the Exelon Long Term Incentive Plan. RSUs are granted annually at the Compensation and Leadership Development Committee's first meeting in January or February and vest in 1/3 increments on the dates of the Committee's January or February meetings held in the first, second, and third years after the grant date. Each RSU represents the right to receive one share of Exelon common stock. Awards accrue additional RSUs acquired through quarterly dividend reinvestment that vest on the same schedule as the underlying award. F2 · derivative.exercise_date: Restricted stock unit (RSUs) award granted pursuant to the Exelon Long Term Incentive Plan. RSUs are granted annually at the Compensation and Leadership Development Committee's first meeting in January or February and vest in 1/3 increments on the dates of the Committee's January or February meetings held in the first, second, and third years after the grant date. Each RSU represents the right to receive one share of Exelon common stock. Awards accrue additional RSUs acquired through quarterly dividend reinvestment that vest on the same schedule as the underlying award. F2 · derivative.expiration_date: Restricted stock unit (RSUs) award granted pursuant to the Exelon Long Term Incentive Plan. RSUs are granted annually at the Compensation and Leadership Development Committee's first meeting in January or February and vest in 1/3 increments on the dates of the Committee's January or February meetings held in the first, second, and third years after the grant date. Each RSU represents the right to receive one share of Exelon common stock. Awards accrue additional RSUs acquired through quarterly dividend reinvestment that vest on the same schedule as the underlying award. Read SEC document |
| February 04, 2019 Filed Feb 6, 2019 22:28 UTC | EXELON CORP EXC · Entity 3050 | Disposition to issuerCommon Stock | 224,802 | $47.34 | $10,642,126.68 |
DisclosureSEC source: 0001109357-19-000028 · edgar.xml · nonDerivative · entry 3 Crane Christopher M. · CIK 0001411453 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 383,640 Read SEC document |
| February 04, 2019 Filed Feb 6, 2019 22:28 UTC | EXELON CORP EXC · Entity 3050 | Tax withholdingCommon Stock | 244,469 | $47.34 | $11,573,162.46 |
DisclosureSEC source: 0001109357-19-000028 · edgar.xml · nonDerivative · entry 2 Crane Christopher M. · CIK 0001411453 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 608,443 Read SEC document |
| February 04, 2019 Filed Feb 6, 2019 22:28 UTC | EXELON CORP EXC · Entity 3050 | Exercise / conversionCommon Stock | 532,340 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001109357-19-000028 · edgar.xml · nonDerivative · entry 1 Crane Christopher M. · CIK 0001411453 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 852,912 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Common shares acquired through conversion of previously awarded and vested restricted stock units (RSUs) and performance share (stock units) under the Exelon Long Term Incentive Plan. Read SEC document |
| January 29, 2018 Filed Jan 31, 2018 20:01 UTC | EXELON CORP EXC · Entity 3050 | Exercise / conversionPerformance Shares- Stock Units · Derivative | 196,046 | $38.33 Strike: $0.00 | $7,514,443.18 |
DisclosureSEC source: 0001109357-18-000033 · edgar.xml · derivative · entry 9 Crane Christopher M. · CIK 0001411453 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 196,046 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Performance share stock units award made pursuant to the Exelon Long Term Incentive Plan for the three-year performance period from January 1, 2015 to December 31, 2017. Shares vest immediately upon award. This grant was settled in cash on a 1 for 1 basis based on the cash value of the underlying stock on the date of vesting because the reporting person had attained 200% of their required stock ownership target. F4 · derivative.expiration_date: Performance share stock units award made pursuant to the Exelon Long Term Incentive Plan for the three-year performance period from January 1, 2015 to December 31, 2017. Shares vest immediately upon award. This grant was settled in cash on a 1 for 1 basis based on the cash value of the underlying stock on the date of vesting because the reporting person had attained 200% of their required stock ownership target. Read SEC document |
| January 29, 2018 Filed Jan 31, 2018 20:01 UTC | EXELON CORP EXC · Entity 3050 | GrantPerformance Shares- Stock Units · Derivative | 196,046 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001109357-18-000033 · edgar.xml · derivative · entry 8 Crane Christopher M. · CIK 0001411453 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 196,046 Underlying: Common stock · 196,046 shares Expires not disclosed F4 · price: Performance share stock units award made pursuant to the Exelon Long Term Incentive Plan for the three-year performance period from January 1, 2015 to December 31, 2017. Shares vest immediately upon award. This grant was settled in cash on a 1 for 1 basis based on the cash value of the underlying stock on the date of vesting because the reporting person had attained 200% of their required stock ownership target. F4 · derivative.exercise_date: Performance share stock units award made pursuant to the Exelon Long Term Incentive Plan for the three-year performance period from January 1, 2015 to December 31, 2017. Shares vest immediately upon award. This grant was settled in cash on a 1 for 1 basis based on the cash value of the underlying stock on the date of vesting because the reporting person had attained 200% of their required stock ownership target. F4 · derivative.expiration_date: Performance share stock units award made pursuant to the Exelon Long Term Incentive Plan for the three-year performance period from January 1, 2015 to December 31, 2017. Shares vest immediately upon award. This grant was settled in cash on a 1 for 1 basis based on the cash value of the underlying stock on the date of vesting because the reporting person had attained 200% of their required stock ownership target. Read SEC document |
| January 29, 2018 Filed Jan 31, 2018 20:01 UTC | EXELON CORP EXC · Entity 3050 | Exercise / conversionRestricted Stock Unit Awards · Derivative | 109,083 | $38.33 Strike: $0.00 | $4,181,151.39 |
DisclosureSEC source: 0001109357-18-000033 · edgar.xml · derivative · entry 7 Crane Christopher M. · CIK 0001411453 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 196,509 Underlying: Common stock · 109,083 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Restricted stock unit awards made pursuant to the Exelon Long Term Incentive Plan. Share awards are made annually in January at the Compensation and Leadership Development committee's meeting and vest in 1/3 increments on the date of the committee's January meeting in the first, second and third years after the award was made. F3 · derivative.expiration_date: Restricted stock unit awards made pursuant to the Exelon Long Term Incentive Plan. Share awards are made annually in January at the Compensation and Leadership Development committee's meeting and vest in 1/3 increments on the date of the committee's January meeting in the first, second and third years after the award was made. Read SEC document |
| January 29, 2018 Filed Jan 31, 2018 20:01 UTC | EXELON CORP EXC · Entity 3050 | GrantRestricted Stock Unit Awards · Derivative | 86,953 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001109357-18-000033 · edgar.xml · derivative · entry 6 Crane Christopher M. · CIK 0001411453 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 305,592 Underlying: Common stock · 86,953 shares Expires not disclosed F3 · price: Restricted stock unit awards made pursuant to the Exelon Long Term Incentive Plan. Share awards are made annually in January at the Compensation and Leadership Development committee's meeting and vest in 1/3 increments on the date of the committee's January meeting in the first, second and third years after the award was made. F3 · derivative.exercise_date: Restricted stock unit awards made pursuant to the Exelon Long Term Incentive Plan. Share awards are made annually in January at the Compensation and Leadership Development committee's meeting and vest in 1/3 increments on the date of the committee's January meeting in the first, second and third years after the award was made. F3 · derivative.expiration_date: Restricted stock unit awards made pursuant to the Exelon Long Term Incentive Plan. Share awards are made annually in January at the Compensation and Leadership Development committee's meeting and vest in 1/3 increments on the date of the committee's January meeting in the first, second and third years after the award was made. Read SEC document |
| January 29, 2018 Filed Jan 31, 2018 20:01 UTC | EXELON CORP EXC · Entity 3050 | Disposition to issuerCommon stock | 107,776 | $38.33 | $4,131,054.08 |
DisclosureSEC source: 0001109357-18-000033 · edgar.xml · nonDerivative · entry 3 Crane Christopher M. · CIK 0001411453 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 320,572 F2 · shares: Shares settled in cash on a 1 for 1 basis. Read SEC document |
| January 29, 2018 Filed Jan 31, 2018 20:01 UTC | EXELON CORP EXC · Entity 3050 | Tax withholdingCommon Stock | 133,482 | $38.33 | $5,116,365.06 |
DisclosureSEC source: 0001109357-18-000033 · edgar.xml · nonDerivative · entry 2 Crane Christopher M. · CIK 0001411453 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 428,348 F1 · shares: Shares withheld by the Issuer for reporting person's tax obligation. Read SEC document |
| January 29, 2018 Filed Jan 31, 2018 20:01 UTC | EXELON CORP EXC · Entity 3050 | Exercise / conversionCommon Stock | 305,129 | $38.33 | $11,695,594.57 |
DisclosureSEC source: 0001109357-18-000033 · edgar.xml · nonDerivative · entry 1 Crane Christopher M. · CIK 0001411453 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 561,830 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 30, 2017 Filed Feb 1, 2017 16:28 UTC | EXELON CORP EXC · Entity 3050 | Exercise / conversionPerformance Shares- Stock Units · Derivative | 263,744 | $35.04 Strike: $0.00 | $9,241,589.76 |
DisclosureSEC source: 0001109357-17-000031 · edgar.xml · derivative · entry 9 Crane Christopher M. · CIK 0001411453 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 263,744 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Performance share stock units award made pursuant to the Exelon Long Term Incentive Plan for the three-year performance period from January 1, 2014 to December 31, 2016. Shares vest immediately upon award. This grant was settled in cash on a 1 for 1 basis based on the cash value of the underlying stock on the date of vesting because the reporting person had attained 200% of their required stock ownership target. F4 · derivative.expiration_date: Performance share stock units award made pursuant to the Exelon Long Term Incentive Plan for the three-year performance period from January 1, 2014 to December 31, 2016. Shares vest immediately upon award. This grant was settled in cash on a 1 for 1 basis based on the cash value of the underlying stock on the date of vesting because the reporting person had attained 200% of their required stock ownership target. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.